Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
VIVUS LLC clinical trials
Part of Icahn Enterprises L.P., which holds 100% as of 2026-03-31. Source
The registry lists 43 studies whose lead sponsor is VIVUS LLC. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 29, 2026.
Keep track of what changes. Save the VIVUS LLC studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- United States
- 35
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to VIVUS LLC.
- VIVUS LLC43 studiesSame company
Something wrong?
Focus areas
Conditions VIVUS LLC leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 43 of 43.
- A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional LimitationsNot yet recruitingNCT07612657Phase 3
- A Study of Carmustine With and Without Ethanol in Subjects With LymphomaRecruitingNCT06915246Phase 2
- A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese SubjectsCompletedNCT05215418Phase 4
- A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With ObesityCompletedNCT03922945Phase 4
- A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese AdolescentsCompletedNCT02714062Phase 4
- Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy SubjectsCompletedNCT02229214Phase 4
- Study Evaluating the Effects of Avanafil on Semen ParametersCompletedNCT01768676Phase 4
- A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in AdultsCompletedNCT00563368Phase 3
- Safety Study Looking at the Effects of Stendra on VisionCompletedNCT02033200Phase 4
- Research Evaluating a PDE5 Inhibitor for Erectile DysfunctionCompletedNCT01698684Phase 4
- VI-1121 for the Treatment Alzheimer's DiseaseCompletedNCT01428362Phase 2
- A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.CompletedNCT00806260Phase 2
- A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese AdultsCompletedNCT00745251Phase 1/2
- Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-ProstatectomyCompletedNCT00895011Phase 3
- Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese DiabeticsCompletedNCT00486291Phase 2
- A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)CompletedNCT00796367Phase 3
- A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic AdultsCompletedNCT00600067Phase 2
- Study of VI-0521 Compared to Placebo in Treatment of Obesity in AdultsCompletedNCT00554216Phase 3
- Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid ConditionsCompletedNCT00553787Phase 3
- Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic AdultsTerminatedNCT00737633Phase 2
- Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile DysfunctionCompletedNCT00853606Phase 3
- Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)CompletedNCT00809471Phase 3
- Research Evaluating an Investigational Medication for Erectile Dysfunction - General EDCompletedNCT00790751Phase 3
- Study to Evaluate Hemodynamic Response to to a Sublingual Dose of Glyceryl Trinitrate in Subjects Receiving TA-1790, Sildenafil Citrate, and PlaceboCompletedNCT01616485Phase 1
- Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male SubjectsCompletedNCT01415128Phase 1
- Drug Interaction Study of Avanafil and Enalapril or AmlodipineCompletedNCT01117038Phase 1
- A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®TerminatedNCT01096329Phase 1
- Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese AdultsCompletedNCT00518466Phase 1
- To Assess the Safety of Avanafil in Healthy and Hepatically Impaired Male Subjects.CompletedNCT01054430Phase 1
- Assess the Effect of Food on Avanafil Pharmacokinetic (PK), to Compare 2 Oral Formulations of Avanafil,and Investigate Dose Proportionality in Healthy Male SubjectsCompletedNCT01095601Phase 1
- A Thorough EKG Safety Study of TA-1790 (Avanafil)CompletedNCT00769041Phase 1
- A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.CompletedNCT01054859Phase 1
- Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and TamsulosinCompletedNCT01100021Phase 1
- Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male SubjectsCompletedNCT01095588Phase 1
- To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.CompletedNCT01054261Phase 1
- A Pharmacokinetic Study of Avanfil in Healthy Young Male SubjectsCompletedNCT00914511Phase 1
- A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female VolunteersCompletedNCT00839891Phase 1
- A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.CompletedNCT00842400Phase 1
- Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female SubjectsCompletedNCT00821496Phase 1
- To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of AvanafilCompletedNCT00770042Phase 1
- A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal ImpairmentCompletedNCT00768404Phase 1
- A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic ImpairmentCompletedNCT00768209Phase 1
- Topical Alprostadil for Female Sexual Arousal DisorderCompletedNCT00324948Phase 2